In this installment of Urology Times' 50th Anniversary Innovation Celebration, Rachel S. Rubin, MD, discusses the evolution in the treatment of female hypoactive sexual desire disorder.
A recent study focused on the prevalence of sexual dysfunction in both men and women with type 1 diabetes (T1D) or type 2 diabetes (T2D) and the associations between clinical and psychological variables.
According to research published in Menopause, vaginal atrophy-a treatable condition-appears to be the most impactful factor for perimenopausal women and declining sexual function.